EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS38 - Dermatology 02

Saturday 14 Jun, 12:00 PM - 13:00 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
Acute generalized exanthematous pustulosis due to iohexol with tolerance to iobitridol
Allergic contact dermatitis caused by a oxybutynin in a transdermal patch
Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023
Blistering Discovery: A Rare Case of Toxic Epidermal Necrolysis Triggered by Carboplatin and Radiotherapy
Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
Diagnostic characterization of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): Case series from a tertiary care hospital and literature review
Fixed Drug Eruption and Its Rare Variants as Food-Related and Generalized Bullous Lesions; A Tale of Three Cases
Fixed Drug Eruption related to the use of NSAIDs
Generalized Acute Eosinophilic Folliculitis Induced by Drugs in an Oncology Patient
Non - immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test
SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
Sodium dodecyl sulfate impairs the skin epithelial barrier by inducing oxidative stress in human skin
Transepidermal Water Loss in Atopic Diseases

Speakers